CytoFLEX S Flow Analyzer to characterize HIV-1 infected and cART-affected cells

September 21, 2022
Sergei Nekhai

Sergei Nekhai, PhD (HU) has received an NIH CFAR Administrative Supplement entitled, “CytoFLEX S Flow Analyzer to characterize HIV-1 infected and cART-affected cells”. 

The instrument will be used by DC CFAR investigators at Howard University. Howard University, at the present, lacks modern Flow cytometry capacity. The CytoFLEX S Flow Analyzer is a revolutionary system presenting optimal excitation and emission, minimizing light loss, and maximizing sensitivity. Since its initial unveiling, the compact system with innovative technology borrowed from the telecommunications industry has garnered attention from the flow cytometry community. The proposed Flow Analyzer acquisition will replace the existing outdated instrument, enhance, and expand the existing instrumental platform and allow many DC CFAR investigators across the Howard University campus to conduct studies that involve fluorescent-based analysis of cells and tissues. Howard University is an HBCU that plays a critical role in the DC CFAR program. The instrument will be incorporated in the DC CFAR Basic Science Core and placed in the Interdisciplinary Research Building to be accessible for DC CFAR researchers. This new service will be managed by Dr. Nekhai whose laboratory will help servicing the instrument, providing training, and tracking the usage. Nekhai’s lab has experience in providing such support. This new instrument will increase the robustness of scientific approaches and enhance the competitiveness of the investigations.